https://www.selleckchem.com/pr....oducts/fadraciclib.h
Hormone therapies, particularly those targeting estrogen and its receptors, are a key treatment modality for patients with estrogen receptor (ER)-positive breast or ovarian cancer. Some gastric cancers (GCs) express ERs, and preclinical studies suggest the potential of estrogen-targeting hormone therapy on GC; however, the clinical relevance of this hormone therapy on GC treatment has not been well elucidated. An 80-year-old female was admitted to our department with hypogastric pain and vomiting. Computed tomography demonstrated sm
Like
Comment
Share
